Business Context and Reporting Period
Company: CopyTele, Inc. (Note: Metadata listed "Anixa Biosciences Inc" is incorrect; the filing is for CopyTele, Inc.)
Reporting Period: Quarterly period ended April 30, 1996 (Six months ended April 30, 1996).
Status: Development Stage Enterprise.
Operations: The company has generated no revenue since inception (November 5, 1982). Principal activities include developing flat panel telecommunications technology (prototype "MAGICOM") and managing a 55% owned joint venture in Shanghai, China (Shanghai CopyTele Electronics Co., Ltd.).
Key Financial Metrics
| Metric | Six Months Ended April 30, 1996 | Six Months Ended April 30, 1995 |
|---|---|---|
| Sales/Revenue | $0 | $0 |
| Net Loss | ($1,966,625) | ($1,330,587) |
| Net Loss Per Share | ($0.07) | ($0.05) |
| Operating Expenses (SG&A) | $2,203,541 | $1,479,329 |
| Research & Development | $1,461,000 (included in SG&A) | $960,000 (included in SG&A) |
| Interest Income | $236,916 | $148,742 |
| Cash and Equivalents (Ending) | $13,908,581 | $6,875,618 |
| Net Cash Used in Operating Activities | ($1,715,998) | ($1,192,097) |
| Net Cash Provided by Financing Activities | $7,402,671 | $1,838,110 |
| Accumulated Deficit (Inception to Date) | ($25,281,595) | N/A |
Liquidity: The company holds significant cash reserves ($13.9M) primarily funded by stock option exercises and prior equity sales. There is no long-term debt reported on the balance sheet.
Material Changes vs. Prior Period
- Increased Operating Loss: Net loss increased by approximately $636,000 (48%) compared to the prior six-month period, driven by higher operating expenses.
- Expense Growth: Selling, general, and administrative expenses rose by $724,212. This increase is attributed to higher engineering supplies/services, initial marketing costs (opening a marketing office, PR/ads), and patent filing fees.
- Joint Venture Impact: The current period includes the company's pro-rata share of losses from the Shanghai joint venture, which was not present in the same capacity in the prior period.
- Financing Activity: Net cash provided by financing activities surged to $7.4 million (from $1.8 million) due to significant proceeds from the exercise of stock options and warrants ($7.4M in the six-month period).
- Cash Position: Cash and cash equivalents increased by $5.0 million during the six-month period, despite negative operating cash flow.
Outlook, Risks, and Management Commentary
- Revenue Uncertainty: Management states there is no assurance that marketable products will be produced or sold in commercial quantities. The company has no revenue history.
- Liquidity Outlook: Management believes current funds are sufficient to maintain development efforts and meet initial capital contributions to joint ventures through fiscal 1999, assuming continued salary waivers by senior executives.
- Joint Venture Capital Needs: The company is required to contribute $1,225,000 to the Shanghai joint venture (has contributed $857,500 as of June 3, 1996). A second joint venture is planned with an anticipated contribution of up to $550,000.
- Listing Requirements: The company must maintain $4,000,000 in net tangible assets to remain listed on NASDAQ-NMS. Management anticipates seeking additional funding if necessary to meet this requirement.
- Stock Split: A two-for-one stock split was declared on May 24, 1996, payable June 17, 1996. Financial statements have not been restated to reflect this.
- Accounting Standards: The impact of SFAS No. 123 (Stock-Based Compensation) is undetermined but will be adopted no later than fiscal 1997.
Investor Verification Checklist
- Revenue Timeline: Verify if the "MAGICOM" prototype has moved toward commercial production or if the timeline for revenue generation has shifted.
- Joint Venture Progress: Confirm the status of the Shanghai joint venture's product development and the timing of the remaining $375,000 capital contribution.
- Executive Compensation: Assess the sustainability of the company's burn rate given the reliance on salary waivers by the Chairman, President, and senior staff.
- Stock Option Dilution: Review the volume of options exercised ($7.4M proceeds in six months) and the remaining pool available under the 1993 Plan to understand potential future dilution.
- NASDAQ Compliance: Monitor net tangible assets to ensure the company maintains the $4,000,000 threshold required for listing.